Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_provenance.
- NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_assertion description "[Because of tumor heterogeneity, the high number of receptors in the PC-3 line may not represent the clinical situation, and little definitive work on the GRP-R status of primary prostate tumors and metastases exists.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_provenance.
- NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_assertion evidence source_evidence_literature NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_provenance.
- NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_assertion SIO_000772 19910427 NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_provenance.
- NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_assertion wasDerivedFrom befree-2016 NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_provenance.
- NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_assertion wasGeneratedBy ECO_0000203 NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_provenance.
- befree-2016 importedOn "2016-02-19" NP775482.RAfQ42VW-se8Kf6EA1iB0m6LUvMJWhhl6Ng4qbThDcD-k130_provenance.